Robert E. Damon

488 total citations
25 papers, 374 citations indexed

About

Robert E. Damon is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert E. Damon has authored 25 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Robert E. Damon's work include Chemical Synthesis and Analysis (4 papers), Synthesis of heterocyclic compounds (3 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Robert E. Damon is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Synthesis of heterocyclic compounds (3 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (3 papers). Robert E. Damon collaborates with scholars based in United States, Switzerland and Japan. Robert E. Damon's co-authors include Gary M. Coppola, R. H. Schlessinger, J. F. BLOUNT, Tao Luo, James R. Paterniti, Dennis S. France, W. Mann, Leonard Brand, Thomas D. Aicher and Jiaping Gao and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron Letters and Synthesis.

In The Last Decade

Robert E. Damon

24 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Damon United States 11 269 134 36 26 22 25 374
D. A. Engler United States 5 300 1.1× 113 0.8× 24 0.7× 30 1.2× 24 1.1× 5 380
Kent Neuenschwander United States 12 248 0.9× 181 1.4× 24 0.7× 29 1.1× 13 0.6× 19 446
Kiyohiro Samizu Japan 13 343 1.3× 120 0.9× 33 0.9× 23 0.9× 16 0.7× 24 430
Philip L. Stotter United States 13 213 0.8× 127 0.9× 25 0.7× 31 1.2× 25 1.1× 24 365
Jeffrey L. Havens United States 7 308 1.1× 123 0.9× 32 0.9× 21 0.8× 28 1.3× 10 436
Jacques Viala France 14 300 1.1× 105 0.8× 88 2.4× 33 1.3× 37 1.7× 32 430
Joseph M. Pawlak United States 6 339 1.3× 156 1.2× 34 0.9× 22 0.8× 12 0.5× 6 398
Philip M. Sher United States 8 466 1.7× 139 1.0× 23 0.6× 40 1.5× 18 0.8× 11 570
Alan M. Birch United Kingdom 11 191 0.7× 165 1.2× 97 2.7× 18 0.7× 15 0.7× 20 402
D. Sivakumar Reddy India 9 267 1.0× 89 0.7× 23 0.6× 17 0.7× 8 0.4× 9 323

Countries citing papers authored by Robert E. Damon

Since Specialization
Citations

This map shows the geographic impact of Robert E. Damon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Damon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Damon more than expected).

Fields of papers citing papers by Robert E. Damon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Damon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Damon. The network helps show where Robert E. Damon may publish in the future.

Co-authorship network of co-authors of Robert E. Damon

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Damon. A scholar is included among the top collaborators of Robert E. Damon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Damon. Robert E. Damon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coppola, Gary M., et al.. (2005). Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents. Bioorganic & Medicinal Chemistry Letters. 16(1). 113–117. 5 indexed citations
2.
Coppola, Gary M., et al.. (2004). 1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agents. Bioorganic & Medicinal Chemistry Letters. 15(3). 809–812. 7 indexed citations
3.
Coppola, Gary M., et al.. (2002). Thiourea-based gemfibrozil analogues as HDL-elevating agents. Bioorganic & Medicinal Chemistry Letters. 12(17). 2439–2442. 7 indexed citations
4.
Coppola, Gary M., et al.. (2000). SYNTHESIS AND CHARACTERIZATION OF ISOMERIC 2,5-DJMETHYL-6-PHENYL-3-CYCLOHEXENE-1-METHANOL ANALOGS. Organic Preparations and Procedures International. 32(1). 75–79. 1 indexed citations
5.
Aicher, Thomas D., et al.. (1999). Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK). Bioorganic & Medicinal Chemistry Letters. 9(15). 2223–2228. 29 indexed citations
6.
Damon, Robert E., et al.. (1998). SYNTHESIS OF A CON FORMATIONALLY RESTRAINED 4-ARYLTHIOPHENE-3-HEPTENOIC ACID AND ITS EVALUATION AS AN HMG COENZYME A REDUCTASE INHIBITOR. Heterocyclic Communications. 4(2). 105–112. 1 indexed citations
7.
Coppola, Gary M., et al.. (1997). Design and biological evaluation of a series of thiophene-based 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 7(5). 549–554. 4 indexed citations
8.
Coppola, Gary M., et al.. (1996). Synthesis of some highly functionalized thiophene‐3‐carboxylates and alcohols. Journal of Heterocyclic Chemistry. 33(3). 687–696. 6 indexed citations
9.
Coppola, Gary M., et al.. (1996). Correlation of oxidation potential and toxicity in thiobenzamides. Bioorganic & Medicinal Chemistry Letters. 6(2). 139–142. 12 indexed citations
10.
Brinkman, J. A., et al.. (1996). Squalene synthase inhibitors: isosteric replacements of the farnesyl chain of benzyl farnesyl amine. Bioorganic & Medicinal Chemistry Letters. 6(21). 2491–2494. 5 indexed citations
11.
Coppola, Gary M., et al.. (1995). Synthesis of Highly Functionalized Thiophenes. 4-Aryl-3-carboxylate Derivatives. Synlett. 1995(11). 1143–1144. 4 indexed citations
12.
Coppola, Gary M. & Robert E. Damon. (1995). Acetylenic amides. 2. The generation and reactions of dianions derived from 2‐propynamides. Journal of Heterocyclic Chemistry. 32(4). 1133–1139. 17 indexed citations
13.
Damon, Robert E. & Gary M. Coppola. (1990). Cleavage of N-acyl oxazolidones. Tetrahedron Letters. 31(20). 2849–2852. 69 indexed citations
14.
Coppola, Gary M. & Robert E. Damon. (1990). 3‐(2‐Pyrrolidinyl)‐2,4‐furandione analogs. Journal of Heterocyclic Chemistry. 27(3). 815–817. 1 indexed citations
15.
Coppola, Gary M., Robert E. Damon, & G. E. HARDTMANN. (1981). 4-Hydroxy-2-quinolinone-3-carboxylic Acids. Synthesis. 1981(5). 391–392. 6 indexed citations
16.
Coppola, Gary M. & Robert E. Damon. (1980). Novel heterocycles. 6. The condensation of ethyl o‐fluorobenzoyl acetate with cyclic imino ethers. Journal of Heterocyclic Chemistry. 17(8). 1729–1731. 10 indexed citations
17.
Coppola, Gary M. & Robert E. Damon. (1979). The chemistry of 2H‐3,1‐benzoxazine‐2,4(1H)dione (isatoic anhydride). 6. Synthesis of spiro[indoline‐2,2′(1′H)quinazolines]. Journal of Heterocyclic Chemistry. 16(7). 1501–1502.
19.
Damon, Robert E. & R. H. Schlessinger. (1976). An efficient and stereospecific total synthesis of dl-protolichesterinic acid. Tetrahedron Letters. 17(19). 1561–1564. 28 indexed citations
20.
Damon, Robert E. & R. H. Schlessinger. (1975). A high yield total synthesis of dl-4-isoavenaciolide. Tetrahedron Letters. 16(51). 4551–4554. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026